Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
Fuster D, Huertas JA, Gómez G, Solà R, González García J, Vilaró J, Pedrol E, Force L, Tor J, Sirera G, Videla S, Planas R, Clotet B, Tural C; PEG-TOX Research Group. Fuster D, et al. Among authors: clotet b. Antivir Ther. 2005;10(7):841-7. Antivir Ther. 2005. PMID: 16312180 Clinical Trial.
Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
Cabrera C, Gutiérrez A, Barretina J, Blanco J, Litovchick A, Lapidot A, Clotet B, Esté JA. Cabrera C, et al. Among authors: clotet b. Antiviral Res. 2002 Jan;53(1):1-8. doi: 10.1016/s0166-3542(01)00188-7. Antiviral Res. 2002. PMID: 11684311
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Negredo E, Cruz L, Paredes R, Ruiz L, Fumaz CR, Bonjoch A, Gel S, Tuldrà A, Balagué M, Johnston S, Arnó A, Jou A, Tural C, Sirera G, Romeu J, Clotet B. Negredo E, et al. Among authors: clotet b. Clin Infect Dis. 2002 Feb 15;34(4):504-10. doi: 10.1086/324629. Epub 2002 Jan 2. Clin Infect Dis. 2002. PMID: 11797178 Clinical Trial.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, González J, Domingo P, Boucher C, Rey-Joly C, Clotet B; Havana Study Group. Tural C, et al. Among authors: clotet b. AIDS. 2002 Jan 25;16(2):209-18. doi: 10.1097/00002030-200201250-00010. AIDS. 2002. PMID: 11807305 Clinical Trial.
Reduced fitness of HIV-1 resistant to CXCR4 antagonists.
Armand-Ugón M, Quiñones-Mateu ME, Gutiérez A, Barretina J, Blanco J, Schols D, De Clercq E, Clotet B, Esté JA. Armand-Ugón M, et al. Among authors: clotet b. Antivir Ther. 2003 Feb;8(1):1-8. Antivir Ther. 2003. PMID: 12713058
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, Domingo P, Vilaró J, Llibre JM, Viciana P, Hertogs K, Boucher C, D'Aquila RT, Clotet B; SWATCH Study Team. Martinez-Picado J, et al. Among authors: clotet b. Ann Intern Med. 2003 Jul 15;139(2):81-9. doi: 10.7326/0003-4819-139-2-200307150-00007. Ann Intern Med. 2003. PMID: 12859157 Clinical Trial.
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Laguna F, Videla S, Jiménez-Mejías ME, Sirera G, Torre-Cisneros J, Ribera E, Prados D, Clotet B, Sust M, López-Vélez R, Alvar J; Spanish HIV-Leishmania Study Group. Laguna F, et al. Among authors: clotet b. J Antimicrob Chemother. 2003 Sep;52(3):464-8. doi: 10.1093/jac/dkg356. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888588 Clinical Trial.
1,146 results